Structure-activity relationships of 1′S-1′-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages

被引:46
作者
Matsuda, H [1 ]
Ando, S [1 ]
Morikawa, T [1 ]
Kataoka, S [1 ]
Yoshikawa, M [1 ]
机构
[1] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan
关键词
1 ' S-1 '-acetoxychavicol acetate; structure-activity relationship; nitric oxide production; phenylpropanoid; lipopolysaccharide; macrophage;
D O I
10.1016/j.bmcl.2005.01.070
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1'S-1'-Acetoxychavicol acetate from the rhizomes of Alpinia galanga inhibited nitric oxide (NO) production in lipopolysaccharide-activated mouse peritoneal macrophages with an IC50 value of 2.3 mu M. To clarify the structure-activity relationship of 1'S-1'-acetoxychavicol acetate, various natural and synthetic phenylpropanoids and synthetic phenylbutanoids were examined, and the following structural requirements were clarified. (1) The para or ortho substitution of the acetoxyl and 1-acetoxypropenyl groups at the benzene ring was essential. (2) The S configuration of the 1'-acetoxyl group was preferable. (3) The presence of the 3-methoxyl group and disappearance of the 2'-3' double bond by hydrogenation reduced the activity. (4) The substitution of acetyl groups with propionyl or methyl groups reduced the activity. (5) Lengthening of the carbon chain between the 1'- and 2'-positions reduced the activity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1949 / 1953
页数:5
相关论文
共 17 条
  • [1] New crinine-type alkaloids with inhibitory effect on induction of inducible nitric oxide synthase from Crinum yemense
    Abdel-Halim, OB
    Morikawa, T
    Ando, S
    Matsuda, H
    Yoshikawa, M
    [J]. JOURNAL OF NATURAL PRODUCTS, 2004, 67 (07): : 1119 - 1124
  • [2] Reaction of singlet oxygen with trans-4-propenylanisole.: Formation of [2+2] products with added acid
    Greer, A
    Vassilikogiannakis, G
    Lee, KC
    Koffas, TS
    Nahm, K
    Foote, CS
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (21) : 6876 - 6878
  • [3] ENANTIOMERIC RESOLUTION OF 1-PHENYL-2-PROPANOL BY PSEUDOMONAS-CEPACIA
    HORIUCHI, K
    KOBASHI, K
    NAGATA, H
    SATOH, T
    SUEMITSU, R
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1994, 58 (07) : 1330 - 1331
  • [4] 1'-ACETOXYCHAVICOL ACETATE AS A POTENT INHIBITOR OF TUMOR PROMOTER-INDUCED EPSTEIN-BARR-VIRUS ACTIVATION FROM LANGUAS-GALANGA, A TRADITIONAL THAI CONDIMENT
    KONDO, A
    OHIGASHI, H
    MURAKAMI, A
    SURATWADEE, J
    KOSHIMIZU, K
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1993, 57 (08) : 1344 - 1345
  • [5] Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity
    LeeChen, SF
    Chen, CL
    Ho, LY
    Hsu, PC
    Chang, JT
    Sun, CM
    Chi, CW
    Liu, TY
    [J]. MUTAGENESIS, 1996, 11 (05) : 519 - 523
  • [6] Absolute stereostructures of polypodane- and octanordammarane-type triterpenes with nitric oxide production inhibitory activity from guggul-gum resins
    Matsuda, H
    Morikawa, T
    Ando, S
    Oominami, H
    Murakami, T
    Kimura, I
    Yoshikawa, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (11) : 3037 - 3046
  • [7] Antiallergic principles from Alpinia galanga:: Structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-α and IL-4 in RBL-2H3 cells
    Matsuda, H
    Morikawa, T
    Managi, H
    Yoshikawa, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3197 - 3202
  • [8] Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats:: structural requirements and mode of action
    Matsuda, H
    Pongpiriyadacha, Y
    Morikawa, T
    Ochi, M
    Yoshikawa, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (01) : 59 - 67
  • [9] Absolute stereostructures of new arborinane-type triterpenoids and inhibitors of nitric oxide production from Rubia yunnanensis
    Morikawa, T
    Tao, J
    Ando, S
    Matsuda, H
    Yoshikawa, M
    [J]. JOURNAL OF NATURAL PRODUCTS, 2003, 66 (05): : 638 - 645
  • [10] MORIKAWA T, IN PRESS CHEM PHARM